Literature DB >> 11179544

Meta-analysis of efficacy and safety of second-generation dihydropyridine calcium channel blockers in heart failure.

T J Cleophas1, R van Marum.   

Abstract

Second-generation dihydropyridine calcium channel blockers slightly increase cardiac index, left ventricular ejection fraction, and exercise treadmill tests in patients with chronic heart failure, and do not increase norepinephrine levels; these drugs seem to be safe and beneficial in this category of patients. A 6% reduction in mortality was found, which, although not significantly different from 0%, does indicate that these drugs do not increase mortality in this category of patients.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11179544     DOI： 10.1016/s0002-9149(00)01413-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  8 in total

1.  Comparative effects of calcium and potassium channel modulators on ischemia/reperfusion injury in the isolated rat heart.

Authors:  Nina Simonovic; Vladimir Jakovljevic; Jovana Jeremic; Zarko Finderle; Ivan Srejovic; Tamara Nikolic Turnic; Isidora Milosavljevic; Vladimir Zivkovic
Journal:  Mol Cell Biochem       Date:  2018-06-19       Impact factor: 3.396

Review 2.  Heart failure.

Authors:  Robert Samuel McKelvie
Journal:  BMJ Clin Evid       Date:  2010-02-25

3.  Calcium channel blockers and outcomes in older patients with heart failure and preserved ejection fraction.

Authors:  Kanan Patel; Gregg C Fonarow; Momanna Ahmed; Charity Morgan; Meredith Kilgore; Thomas E Love; Prakash Deedwania; Wilbert S Aronow; Stefan D Anker; Ali Ahmed
Journal:  Circ Heart Fail       Date:  2014-10-08       Impact factor: 8.790

Review 4.  Heart failure.

Authors:  Robert Samuel McKelvie
Journal:  BMJ Clin Evid       Date:  2011-08-30

Review 5.  Beta blockers as anti-arrhythmic agents.

Authors:  Daejoon Anh; Joseph E Marine
Journal:  Heart Fail Rev       Date:  2004-04       Impact factor: 4.214

6.  Clinical evidence review: best practice heart failure.

Authors:  Anthony E Steimle
Journal:  Perm J       Date:  2007

7.  Cardiotoxic and cardioprotective features of chronic β-adrenergic signaling.

Authors:  Xiaoying Zhang; Christopher Szeto; Erhe Gao; Mingxin Tang; Jianguo Jin; Qin Fu; Catherine Makarewich; Xiaojie Ai; Ying Li; Allen Tang; Jenny Wang; Hui Gao; Fang Wang; Xinyi Joy Ge; Satya P Kunapuli; Lin Zhou; Chunyu Zeng; Kevin Yang Xiang; Xiongwen Chen
Journal:  Circ Res       Date:  2012-10-25       Impact factor: 17.367

Review 8.  Calcium channel blockers.

Authors:  William J Elliott; C Venkata S Ram
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-07-27       Impact factor: 3.738
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.